title: Modeling Key Malaria Drugs' Impact on Global Health: A Reason to Invest in the Global Health Impact Index.
abstract: Millions of people cannot access good quality essential medicines they need for some of the world's worst diseases like malaria. The World Health Organization estimates that, in 2013, 198 million people became sick with malaria and 584,000 people died of the disease, while the Institute for Health Metrics Evaluation estimates that there were 164,929,872 cases of malaria in 2013 and 854,568 deaths in 2013. There are many attempts to model different aspects of the global burden of tropical diseases like malaria, but it is also important to measure success in averting malaria-related death and disability. This perspective proposes investing in a systematic effort to measure the benefits of health interventions for malaria along the lines of a model embodied in the Global Health Impact Index (global-health-impact.org).
authors: Department of Philosophy, Binghamton University, Binghamton, New York nhassoun@binghamton.edu.
authors: Nicole
authors: N
authors: Hassoun
mesh_terms: D000962:Antimalarials / Q000627:therapeutic use*; D014943:Global Health; D006801:Humans; D008288:Malaria / Q000188:drug therapy* / Q000401:mortality / Q000517:prevention & control*; D008962:Models, Theoretical
chemical_list: D000962:Antimalarials